Cargando…
Theranostic Cancer Treatment Using Lentinan-Coated Selenium Nanoparticles and Label-Free CEST MRI
Selenium nanoparticle (SeNP)-based nanotherapeutics have become an emerging cancer therapy, while effective drug delivery remains a technical hurdle. A theranostic approach, through which imaging companions are integrated with SeNPs, will allow image-guided drug delivery and, therefore, is highly de...
Autores principales: | Liu, Guanfu, Ling, Jiabao, He, Lizhen, Xu, Yuan, Chen, Tianfeng, Shi, Changzheng, Luo, Liangping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864256/ https://www.ncbi.nlm.nih.gov/pubmed/36678748 http://dx.doi.org/10.3390/pharmaceutics15010120 |
Ejemplares similares
-
CEST theranostics: label-free MR imaging of anticancer drugs
por: Li, Yuguo, et al.
Publicado: (2016) -
The Pursuit of Theranostics with CEST MRI
por: Pagel, Mark Marty
Publicado: (2016) -
Mitigation of Acetamiprid Residue Disruption on Pea Seed Germination by Selenium Nanoparticles and Lentinans
por: Lin, Yongxi, et al.
Publicado: (2023) -
Designing multifunctional cancer-targeted nanosystem for magnetic resonance molecular imaging-guided theranostics of lung cancer
por: Gao, Peng, et al.
Publicado: (2018) -
Label-free CEST MRI Detection of Citicoline-Liposome Drug Delivery in Ischemic Stroke
por: Liu, Huanling, et al.
Publicado: (2016)